JP2023506258A5 - - Google Patents

Info

Publication number
JP2023506258A5
JP2023506258A5 JP2022536726A JP2022536726A JP2023506258A5 JP 2023506258 A5 JP2023506258 A5 JP 2023506258A5 JP 2022536726 A JP2022536726 A JP 2022536726A JP 2022536726 A JP2022536726 A JP 2022536726A JP 2023506258 A5 JP2023506258 A5 JP 2023506258A5
Authority
JP
Japan
Prior art keywords
nucleotide
dsrna agent
nucleotides
agent according
modifications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022536726A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023506258A (ja
JP7797388B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/064776 external-priority patent/WO2021126734A1/en
Publication of JP2023506258A publication Critical patent/JP2023506258A/ja
Publication of JP2023506258A5 publication Critical patent/JP2023506258A5/ja
Priority to JP2025279760A priority Critical patent/JP2026086393A/ja
Application granted granted Critical
Publication of JP7797388B2 publication Critical patent/JP7797388B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022536726A 2019-12-16 2020-12-14 パタチン様ホスホリパーゼドメイン含有3(PNPLA3)iRNA組成物およびその使用法 Active JP7797388B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025279760A JP2026086393A (ja) 2019-12-16 2025-12-24 パタチン様ホスホリパーゼドメイン含有3(PNPLA3)iRNA組成物およびその使用法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962948445P 2019-12-16 2019-12-16
US62/948,445 2019-12-16
US202063040602P 2020-06-18 2020-06-18
US63/040,602 2020-06-18
PCT/US2020/064776 WO2021126734A1 (en) 2019-12-16 2020-12-14 Patatin-like phospholipase domain containing 3 (pnpla3) irna compositions and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025279760A Division JP2026086393A (ja) 2019-12-16 2025-12-24 パタチン様ホスホリパーゼドメイン含有3(PNPLA3)iRNA組成物およびその使用法

Publications (3)

Publication Number Publication Date
JP2023506258A JP2023506258A (ja) 2023-02-15
JP2023506258A5 true JP2023506258A5 (cg-RX-API-DMAC7.html) 2023-12-18
JP7797388B2 JP7797388B2 (ja) 2026-01-13

Family

ID=76437193

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022536726A Active JP7797388B2 (ja) 2019-12-16 2020-12-14 パタチン様ホスホリパーゼドメイン含有3(PNPLA3)iRNA組成物およびその使用法

Country Status (1)

Country Link
JP (1) JP7797388B2 (cg-RX-API-DMAC7.html)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018510621A (ja) 2015-02-13 2018-04-19 アルナイラム ファーマシューティカルズ, インコーポレイテッドAlnylam Pharmaceuticals, Inc. パタチン様ホスホリパーゼドメイン含有3(PNPLA3)iRNA組成物およびその使用方法

Similar Documents

Publication Publication Date Title
JP2021518125A5 (cg-RX-API-DMAC7.html)
JP7442574B2 (ja) Lpaの遺伝子発現の阻害のための組成物及び方法
TWI870358B (zh) 用於抑制17β-HSD第13型(HSD17B13)表現之RNAi藥劑、其組合物及使用方法
JP2023530461A5 (cg-RX-API-DMAC7.html)
JP2024081668A5 (cg-RX-API-DMAC7.html)
JP2024515423A5 (cg-RX-API-DMAC7.html)
JP2022553348A5 (cg-RX-API-DMAC7.html)
JP2023103244A5 (cg-RX-API-DMAC7.html)
JP6752151B2 (ja) 遺伝子サイレンシングにおいて低下したoff−target効果を有するunaオリゴマー
JP2023536974A5 (cg-RX-API-DMAC7.html)
JP2023537943A5 (cg-RX-API-DMAC7.html)
JP2024508896A5 (cg-RX-API-DMAC7.html)
JP2018529732A5 (cg-RX-API-DMAC7.html)
JP2018530529A5 (cg-RX-API-DMAC7.html)
JP2023519274A5 (cg-RX-API-DMAC7.html)
JP2023514336A5 (cg-RX-API-DMAC7.html)
JP2024516356A5 (cg-RX-API-DMAC7.html)
JP2018536689A5 (cg-RX-API-DMAC7.html)
JP2026062630A5 (cg-RX-API-DMAC7.html)
JP2024522996A5 (cg-RX-API-DMAC7.html)
CN116514890A (zh) 用于B型肝炎病毒感染的RNAi剂
RU2015154721A (ru) КОМПОЗИЦИИ НА ОСНОВЕ RNAi SERPINA1 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
JP2024538859A5 (cg-RX-API-DMAC7.html)
JP2018510621A5 (cg-RX-API-DMAC7.html)
JP2023529903A5 (cg-RX-API-DMAC7.html)